A just in time mobile stress intervention for breast cancer survivors
E
Evan James Jordan
Primary Investigator
Enrolling By Invitation
18-100 years
All
Phase
N/A
30 participants needed
6 Locations
Brief description of study
What is the purpose of this study?
The purpose of this study is to design, build, and test a mobile phone app called MOSAIC to address stress as it is experienced by breast cancer survivors in real time.
THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic.
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office
Email: iutrials@iu.edu
Phone: (317) 278-5632
Detailed description of study
What will happen during the study?
- Participants will join five 2-hour meetings to co-develop an app that provides strategies for managing stress related to cancer survivorship.
- Participants with breast cancer will be asked to give opinions and feedback on the design of the mobile app.
- Participants will test and review the app once the design is complete.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Breast Cancer, Stress
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria:
- Previously diagnosed with stage I-III breast cancer,
- Has completed surgery, radiation therapy, chemotherapy, and/or biologic therapy ≤5 years prior (ongoing hormonal therapy is allowed),
- Able to speak and read English (There are not sufficient study resources to translate all documents and app data into other languages),
- Have participated in an ACT intervention
Exclusion Criteria:
- Co-morbidities that would impair participation in the study, including reduced cognitive function, severe depressive symptoms, active substance abuse or uncontrolled bipolar disorder, psychosis, or schizophrenia.
Updated on
01 Aug 2024.
Study ID: 15829, PSY-IIR-IUSCCC-0800
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
